Neurogene Inc. NGNE | $51.12M | 7.74 | 1M | +1.01% | +$512,155.80 | 8.56 | |
VistaGen Therapeutics, Inc. VTGN | $9.81M | 6.88 | 1.86M | 0% | +$0 | 1.64 | |
UroGen Pharma Ltd. URGN | $39.31M | 6.37 | 2.62M | 0% | +$0 | 6.59 | |
Outlook Therapeutics, Inc. OTLK | $17.67M | 6.32 | 1.48M | New | +$17.67M | 2.96 | |
OptiNose, Inc. OPTN | $12.83M | 6.07 | 8.79M | -0.61% | -$78,286.66 | 2.15 |